Issue 9/2024
Momcheva, I., Kazmin, I.
To date, experience with TNF-α inhibitors has addressed many questions for Bulgarian physicians regarding their efficacy, safety, mechanism of action, and pharmacological variations among different preparations. Their use in clinical practice has significantly improved the quality of life for patients with inflammatory joint diseases, including their work capacity and socialization. The accumulated knowledge provides confidence in the use of this group of medications and helps physicians to assess the potential link between their administration and possible adverse events.
Key words: TNF-α inhibitors, efficacy, safety, biological agents
Аddress for correspondence:
Momcheva, I.
Rheumatology, UMBAL – Burgas
73, “Stefan Stambolov”, Blvd.
8000, Bourgas